SweDeliver
Research forum in drug delivery, focusing on new strategies for parenteral, oral and pulmonary drug delivery.
News
- Marcus Wanselius: "I enjoy going to work every single day" 2023-09-25
- Sara Mangsbo appointed new Professor at Uppsala University 2023-09-25
- Four thumbs up for SweDeliver summer internship at AstraZeneca 2023-09-20
- Vinnova research grant to collaboration between SweDeliver, Emplicure AB and Uppsala University 2023-09-18
- SweDeliver's summer internships adding value to all parties 2023-09-08
Seminars & Events
-
Half-time seminar: Self-assembly of therapeutic peptides
-
Dissertation: Marcus Wanselius • Development and characterization of an in vitro method for interaction studies between polymers and pharmaceuticals
-
Half-time seminar: Artificial colonic mucus development as in vitro drug diffusion testing platform
-
Half-time seminar: Drug delivery platform for optimal intestinal absorption of oral antibiotics
-
–
New Horizons in Drug Delivery and Formulations 2023
Summer internship 23
Amanda Gustafsson
“My work at Strike Pharma was a highly educational experience”
Researcher Profile
Christel Bergström
"Uppsala's Life science hub is at the highest international level"
Upcoming Dissertation
Friday 20 october, 13.15
Marcus Wanselius • BMC A1:107a and online via Zoom
Int'l Conference
27-29 November • UKK
New Horizons in Drug Delivery and Formulation 2023
This is SweDeliver
SweDeliver is a world leading research and competence centre in Drug Delivery. Many novel molecules in the drug discovery and development pipeline are biological compounds such as proteins, peptides and RNA. These display problems of poor solubility, membrane permeability and low bioavailability. Thus, the Drug Delivery area is today facing tremendous challenges to develop new drug therapies.
SweDeliver was established in response to these challenges. Based on a multi-disciplinary collaboration between academia and industry with financial support from Vinnova (Sweden’s Innovation Agency), the Faculty of Pharmacy at Uppsala University is the academic hub of the Centre with 16 industrial partners contributing expertise and research infrastructure as well as industrial perspectives and needs within the three main research areas of the Centre.
SweDeliver has prioritized to focus on outstanding research challenges within
- Parenteral Drug Delivery
- Oral Drug Delivery
- Pulmonary Drug Delivery
The research will ultimately lead to development of new and improved drug therapies with respect to both efficacy and patient safety. The Centre will also further support the strong research environment and the drug delivery ecosystem in the Nordic region.
